October 20, 2023, 4:00 PM EDT / 22:00 CET

NEWS RELEASE - REGULATED

October 20, 2023, 4:00 PM EDT / 22:00 CET

Mdxhealth's New Share Capital Amount

and New Number of Shares

IRVINE, CA, and HERSTAL, BELGIUM -

October 20, 2023 - MDxHealth SA (NASDAQ/Euronext: MDXH) ("mdxhealth" or the "Company"), a commercial-stage

precision diagnostics company, today a announces, in accordance with Article 15 of the Belgian Act of May 2, 2007 on the disclosure of

major participations in issuers of which shares are admitted to trading on a regulated market and regarding miscellaneous provisions,

that in the context of a capital increase completed on October 20, 2023, the Company's share capital has increased from EUR 163,471,629.58

to EUR 164,302,752.89 and the number of issued and outstanding shares has increased from 270,380,936 to 272,880,936 ordinary shares, through

the issuance of a total of 2,500,000 new shares. The new shares were issued pursuant to the amendment, announced on August 23, 2023, to

the asset purchase agreement for the acquisition by the Company of the Oncotype DX GPS (Genomic Prostate Score ) test from Genomic

Health, Inc. (a subsidiary of Exact Sciences Corporation).

In addition to the outstanding shares of the Company:

mdxhealth is a commercial-stage precision diagnostics

company that provides actionable molecular information to personalize patient diagnosis and treatment. The Company's tests are based

on proprietary genomic, epigenetic (methylation) and other molecular technologies and assist physicians with the diagnosis and prognosis

of urologic cancers and other urologic diseases. The Company's U.S. headquarters and laboratory operations are in Irvine, California,

with additional laboratory operations in Plano, Texas. European headquarters are in Herstal, Belgium, with laboratory operations in Nijmegen,

and linkedin.com/company/mdxhealth.

For more information:

NOTE: The mdxhealth logo, mdxhealth,

Confirm mdx, Select mdx, Resolve mdx, Genomic Prostate Score, GPS and Monitor mdx are trademarks or registered trademarks of MDxHealth

SA. All other trademarks and service marks are the property of their respective owners.